MENU

PHAT Phathom Pharmaceuticals Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PHAT is expected to report earnings to fall 8.33% to -121 cents per share on March 04

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q4'24
Est.
$-1.21
Q3'24
Beat
by $0.15
Q2'24
Missed
by $0.24
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.27
The last earnings report on November 07 showed earnings per share of -132 cents, beating the estimate of -147 cents. With 581.65K shares outstanding, the current market capitalization sits at 572.32M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

PHAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TCRX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+2.83%
TCRX - PHAT
33%
Loosely correlated
-1.33%
ABP - PHAT
32%
Poorly correlated
-3.91%
ALDX - PHAT
32%
Poorly correlated
+5.34%
ABOS - PHAT
30%
Poorly correlated
-0.51%
ROIV - PHAT
30%
Poorly correlated
+0.41%
More